SVB FINANCIAL GROUP - Q1 2023 holdings

$52.3 Million is the total value of SVB FINANCIAL GROUP's 28 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 33.3% .

 Value Shares↓ Weighting
COIN  COINBASE GLOBAL INC$27,499,166
+90.9%
406,9730.0%52.61%
+33.6%
OKTA SellOKTA INCcl a$8,612,961
+12.5%
99,872
-10.8%
16.48%
-21.2%
 ROOT INCcl a$3,531,384
+0.4%
783,0120.0%6.76%
-29.7%
NewORCHESTRA BIOMED HOLDINGS INC$2,486,721127,068
+100.0%
4.76%
AXSM  AXSOME THERAPEUTICS INC$2,087,806
-20.0%
33,8490.0%3.99%
-44.0%
FROG BuyJFROG LTD$1,876,455
+17.0%
95,251
+26.7%
3.59%
-18.1%
NewSTRUCTURE THERAPEUTICS INCsponsored ads$841,04835,353
+100.0%
1.61%
SellDICE THERAPEUTICS INC$832,741
-37.0%
29,066
-31.4%
1.59%
-55.9%
CMAX  CAREMAX INC$801,000
-26.8%
300,0000.0%1.53%
-48.8%
PATH NewUIPATH INCcl a$790,70945,029
+100.0%
1.51%
 PLANET LABS PBC$676,341
-9.7%
172,0970.0%1.29%
-36.8%
 ROVER GROUP INC$478,069
+23.4%
105,5340.0%0.92%
-13.6%
 MOONLAKE IMMUNOTHERAPEUTICSclass a ord$345,940
+103.7%
16,1730.0%0.66%
+42.7%
CGEM SellCULLINAN ONCOLOGY INC$207,403
-27.3%
20,274
-25.0%
0.40%
-49.1%
GBIO SellGENERATION BIO CO$173,724
-16.5%
40,401
-23.7%
0.33%
-41.5%
SKLZ  SKILLZ INC$162,499
+17.1%
273,9360.0%0.31%
-17.9%
SellCARIBOU BIOSCIENCES INC$146,657
-50.4%
27,619
-41.3%
0.28%
-65.2%
ALVR SellALLOVIR INC$135,595
-38.6%
34,415
-20.0%
0.26%
-57.0%
PACB  PACIFIC BIOSCIENCES CALIF IN$118,683
+41.6%
10,2490.0%0.23%
-0.9%
KNTE SellKINNATE BIOPHARMA INC$97,425
-31.7%
15,588
-33.3%
0.19%
-52.3%
NewMOVELLA HOLDINGS INC$75,57555,570
+100.0%
0.14%
SellPARDES BIOSCIENCES INC$75,109
-43.0%
56,901
-26.9%
0.14%
-60.0%
ELDN SellELEDON PHARMACEUTICALS INC$63,583
-31.7%
26,942
-33.7%
0.12%
-52.0%
SellNOGIN INC$57,612
-82.4%
21,220
-95.0%
0.11%
-87.7%
 MONEYLION INCcl a$42,343
-8.4%
74,5730.0%0.08%
-35.7%
VERO  VENUS CONCEPT INC$35,040
-31.6%
160,0000.0%0.07%
-52.1%
 GROVE COLLAB HOLD INC$12,842
+9.8%
29,3200.0%0.02%
-21.9%
 GREENLIGHT BIOSCIENCES HLDS P$7,329
-63.4%
16,9500.0%0.01%
-74.5%
ExitTEMPO AUTOMATION HOLDINGS IN$0-20,813
-100.0%
-0.04%
FULC ExitFULCRUM THERAPEUTICS INC$0-22,422
-100.0%
-0.06%
ExitWAG GROUP CO$0-42,262
-100.0%
-0.36%
ExitSELINA HOSPITALITY PLC$0-50,217
-100.0%
-0.37%
KROS ExitKEROS THERAPEUTICS INC$0-4,653
-100.0%
-0.61%
ExitOWLET INC$0-881,458
-100.0%
-1.35%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COINBASE GLOBAL INC4Q3 202357.5%
OKTA INC4Q3 202320.9%
ROOT INC4Q3 202314.0%
AXSOME THERAPEUTICS INC4Q3 20237.1%
CAREMAX INC4Q3 20233.0%
PLANET LABS PBC4Q3 20232.0%
MOONLAKE IMMUNOTHERAPEUTICS4Q3 20231.7%
ROVER GROUP INC4Q3 20231.2%
CULLINAN ONCOLOGY INC4Q3 20230.8%
CARIBOU BIOSCIENCES INC4Q3 20230.8%

View SVB FINANCIAL GROUP's complete holdings history.

Latest significant ownerships (13-D/G)
SVB FINANCIAL GROUP Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ACHIEVE LIFE SCIENCES, INC.February 10, 20231,716,7648.8%
Root, Inc.February 10, 2023783,0128.6%
BigCommerce Holdings, Inc.February 12, 2021392,2240.6%
ISC8 INC. /DEFebruary 17, 201534,533,21311.9%

View SVB FINANCIAL GROUP's complete significant-ownership history.

Latest filings
TypeFiled
8-K2024-03-22
8-K2024-03-20
8-K2024-02-26
13F-HR2024-02-14
SC 13G/A2024-02-14
8-K2024-02-09
8-K2024-02-01
8-K2024-01-29
SC 13G/A2024-01-17
8-K2024-01-10

View SVB FINANCIAL GROUP's complete filings history.

Compare quarters

Export SVB FINANCIAL GROUP's holdings